Earnings History Data for Aptevo Therapeutics (APVO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Aptevo Therapeutics

Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	PM	APVO	Aptevo Therapeutics	3.00	-0.48	-0.57	0.00	Aptevo Therapeutics Non-GAAP EPS of -$0.48 [11/7/2024 9:25 AM]	0.3101	0.05 (20.19%)	0.26	0.0 (0.62%)	0.14 - 11.45	3,855,450	3,110,000	3,385,775
Aptevo Therapeutics Non-GAAP EPS of -$0.48 [11/7/2024 9:25 AM] Aptevo Therapeutics Reports 3Q 2024 Financial Results and Provides a Business Update [2024-11-07 08:05AM]
08-05-2024	PM	APVO	Aptevo Therapeutics	0.00	-9.95	-14.10	0.00	Aptevo Therapeutics GAAP EPS of -$9.95 beats by $2.90 [5/8/2024 11:25 AM]	1.02	-0.14 (-11.64%)	1.15	-0.01 (-0.86%)	0.67 - 80.96	332,413	3,740,000	11,454
Aptevo Therapeutics GAAP EPS of -$9.95 beats by $2.90 [5/8/2024 11:25 AM]
14-11-2023	PM	APVO	Aptevo Therapeutics	2.00	-0.50	-0.72	0.00	Aptevo Therapeutics GAAP EPS of -$0.50 [11/14/2023 9:46 AM]	0.1901	0.01 (6.32%)	0.19	0.01 (5.03%)	0.15 - 7.20	914,873	790,000	3,427
Aptevo Therapeutics GAAP EPS of -$0.50 [11/14/2023 9:46 AM]
10-11-2022	PM	APVO	Aptevo Therapeutics	14.00	-1.53	-1.64	0.00	Aptevo Therapeutics GAAP EPS of -$1.50 beats by $0.14 [11/10/2022 8:54 AM]	2.90	0.13 (4.69%)	2.81	0.04 (1.44%)	2.67 - 22.08	7,934	20,000	631
Aptevo Therapeutics GAAP EPS of -$1.50 beats by $0.14 [11/10/2022 8:54 AM] Aptevo Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights [Nov-10-22 08:05AM] Alligator Bioscience & Aptevo Therapeutics Announce Publication Highlighting ALG.APV-527 Preclinical Data in Peer-Reviewed Journal Molecular Cancer Therapeutics [Nov-09-22 08:05AM]
12-05-2022	PM	APVO	Aptevo Therapeutics	20.00	-1.59	-1.15	0.00	Aptevo Therapeutics GAAP EPS of -$1.59 misses by $0.66, revenue of $3.11M misses by $0.64M [5/12/2022 8:45 AM]	4.14	0.33 (8.51%)	3.63	-0.19 (-4.97%)	3.45 - 31.76	79,435	40,000	424
Aptevo Therapeutics GAAP EPS of -$1.59 misses by $0.66, revenue of $3.11M misses by $0.64M [5/12/2022 8:45 AM] Aptevo Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights [May-12-22 08:05AM]
12-11-2021	PM	APVO	Aptevo Therapeutics	63.00	-1.45	-1.48	0.00	Aptevo Therapeutics EPS beats by $0.03, misses on revenue [11/12/2021 8:30 AM]	11.64	-1.11 (-8.71%)	0.0	0.0 (0.00%)	11.55 - 51.75	178,662	70,000	0
Aptevo Therapeutics EPS beats by $0.03, misses on revenue [11/12/2021 8:30 AM] Aptevo Therapeutics Reports Third Quarter Financial Results With Business Highlights [Nov-12-21 08:05AM] Alligator Bioscience and Aptevo Therapeutics Announce a Poster Presentation of ALG.APV-527 at SITC Annual Meeting 2021 [Nov-11-21 04:45PM] Aptevo Therapeutics Announces Preclinical Data for Bispecific Antibody APVO603 at the Society for Immunology in Cancer Annual Meeting [Nov-11-21 08:30AM]
12-08-2021	PM	APVO	Aptevo Therapeutics Inc.	78.49	-1.78	-1.95	-2.10	Aptevo Therapeutics EPS beats by $0.06, beats on revenue [8/12/2021 8:45 AM]	16.77	0.34 (2.07%)	16.40	-0.03 (-0.18%)	6.17 - 60.00	28,596	20,000	123
Aptevo Therapeutics EPS beats by $0.06, beats on revenue [8/12/2021 8:45 AM] Aptevo Therapeutics Reports Second Quarter Financial Results with Business Highlights [Aug-12-21 08:05AM]
11-05-2021	PM	APVO	Aptevo Therapeutics Inc.	105.00	-1.74	-1.62	0.00	Aptevo Therapeutics EPS misses by $0.12, misses on revenue [5/11/2021 9:23 AM]	21.99	-0.11 (-0.50%)	0.0	0.0 (0.00%)	4.62 - 60.00	54,679	40,000	0
Aptevo Therapeutics EPS misses by $0.12, misses on revenue [5/11/2021 9:23 AM] Aptevo Therapeutics Reports First Quarter 2021 Financial Results [May-11-21 09:00AM]
31-03-2021	PM	APVO	Aptevo Therapeutics Inc.	121.99	N/A	-1.79	0.00	Aptevo Therapeutics EPS misses by $0.66, beats on revenue [3/31/2021 8:40 AM]	29.93	1.73 (6.13%)	0.0	0.0 (0.00%)	3.06 - 60.00	58,529	40,000	0
Aptevo Therapeutics EPS misses by $0.66, beats on revenue [3/31/2021 8:40 AM] Aptevo Therapeutics Reports 2020 Financial Results and Provides Business Update [Mar-31-21 08:00AM]
10-11-2020	AH	APVO	Aptevo Therapeutics Inc.	143.28	-2.15	-2.05	-3.22	Aptevo Therapeutics EPS misses by $0.10, beats on revenue [11/10/2020 4:45 PM]	44.72	2.42 (5.73%)	42.03	-0.27 (-0.64%)	2.94 - 60.00	429,252	10,603,555	1,708

14-08-2020	PM	APVO	Aptevo Therapeutics Inc.	25.44	-2.10	-2.27	-4.20	Aptevo Therapeutics EPS beats by $0.02, beats on revenue [8/14/2020 9:28 AM]	8.85	0.88 (11.04%)	8.50	0.53 (6.65%)	2.94 - 12.04	111,330	95,165	3,847